Deep Brain Stimulation (DBS) Devices Market By Product Type (Single-Channel Deep Brain Stimulation Devices, Dual-Channel Deep Brain Stimulation Devices); By Application (Parkinson’s Disease, Essential Tremor, Dystonia, Obsessive-Compulsive Disorder [OCD], Epilepsy, Other Neurological Disorders); By End User (Hospitals, Neurological Clinics, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

Deep Brain Stimulation Devices Market: A Pathway to Revolutionizing Neurological Treatments with a Projected Market Boom by 2030

The deep brain stimulation (dbs) devices market was estimated at approximately $1.5 Bn in 2023 & is witnessed to grow at a CAGR of 9.8% from 2024-2030, reaching an estimated market size of $3.2 Bn by 2030. The rising geriatric population, growing awareness of DBS therapies, and expanding applications in developed and emerging markets are key factors contributing to this growth.

 

DBS devices are implantable neurostimulators that deliver electrical impulses to specific brain regions, effectively modulating neural activity to alleviate symptoms associated with movement disorders like dystonia, parkinson's disease & essential tremor. The rising incidence of these conditions and an aging global population have increased the demand for innovative therapeutic solutions like DBS.

 

Deep Brain Stimulation Devices Market Dynamics: Unveiling the Forces Shaping the Future of Neurostimulation

Deep Brain Stimulation Devices Market Drivers: Unlocking Growth Through Rising Neurological Disorders and Technological Advancements

Rising Incidence of Neurological Disorders: The growing number of patients who suffer from neurological conditions such as Parkinson's disease, epilepsy and essential tremor is a key driver for the Deep Brain Stimulation devices market. Parkinson’s disease affects more than 10 Mn people globally, and approximately 1% of individuals over the age of 60 are diagnosed with the condition annually. The global incidence of epilepsy is about 50 Mn cases, most of which are resistant to medication, requiring advanced treatments like DBS.

Advancements in DBS Technology: Modern DBS devices feature rechargeable batteries, reducing the need for frequent surgical replacements. These advancements also allow for extended device life, improving patient convenience and reducing healthcare costs. Devices are becoming smaller & more compact, improving patient comfort. Wireless capabilities now enable remote monitoring & adjustments which reduces the need for hospital visits. These advancements have significantly improved patient outcomes ultimately making DBS a safer, more precise & accessible treatment option for neurological disorders.

 

Deep Brain Stimulation Devices Market Opportunities: Capitalizing on Emerging Applications and Regional Expansions

Expansion of DBS Applications: DBS devices are being increasingly used for conditions beyond Parkinson’s disease, including treatment-resistant depression, OCD, and chronic pain. In 2021, the FDA approved DBS for OCD under a Humanitarian Device Exemption (HDE). Studies show that DBS devices show efficacy rates of over 60% in treatment-resistant depression patients.

Growth in Emerging Markets: Developing countries in the Asia-Pacific region, present significant growth opportunities due to increasing healthcare infrastructure, growing awareness & an expanding patient base. The Asia-Pacific DBS market is projected to grow at a CAGR of 12.5% from 2024 - 2030, driven by rising healthcare expenditures in countries such as China and India.

 

Deep Brain Stimulation Devices Market Challenges: Navigating Cost Barriers and Regulatory Complexities

High Cost of DBS Procedures: The substantial costs associated with DBS devices & surgical implantation limit their accessibility, especially in low- & middle-income countries. The average cost of a DBS implantation procedure ranges between $35,000 - $70,000, which remains unaffordable for many patients without insurance coverage.

Risk of Complications & Adverse Effects: DBS implantation involves surgical risks such as infections, bleeding & hardware malfunctions. Adverse effects like mood changes or speech problems deter some patients. Studies show that up to 10% of patients undergoing DBS may experience complications such as infections or device-related issues, necessitating corrective procedure.

 

Deep Brain Stimulation Devices Market Segmentation: Mapping the Market by Application, Product and Region

By Product Type

• Single-Channel Deep Brain Stimulation Devices

• Dual-Channel Deep Brain Stimulation Devices

 

By Application

• Parkinson’s Disease

• Essential Tremor

• Dystonia

• Obsessive-Compulsive Disorder (OCD)

• Epilepsy

• Other Neurological Disorders

 

By End User

• Hospitals

• Neurological Clinics

• Ambulatory Surgical Centers

 

By Region

• North America

• Europe

• Asia-Pacific

• Latin America

• Middle East & Africa

 

Deep Brain Stimulation Devices Segment Analysis: Understanding the Leading Applications Driving Market Growth

By Product Type

Leading Segment: Dual-Channel DBS Devices

Dual-channel devices accounts for approximately 60% of the global market share due to their advanced functionality & widespread adoption in treating complex disorders. Dual-channel DBS devices dominate the market due to their ability to stimulate two regions of the brain simultaneously, offering effective treatment for bilateral neurological conditions like Parkinson's disease. Preference among healthcare providers for dual-channel systems, especially for progressive neurological diseases.

 

Fastest-Growing Segment: Single-Channel DBS Devices

Single-Channel DBS Devices segment is projected to grow at a CAGR of 8.5% from 2024 - 2030, supported by demand from regions with limited healthcare budgets. Due to their cost-effectiveness and simpler design, single-channel devices are witnessing growth in emerging markets.

 

By Application

Leading Segment: Parkinson’s Disease

Parkinson’s disease accounted for nearly 55% of the global market share in 2023, driven by the increasing prevalence of the condition, affecting 10 Mn people worldwide (WHO). It is the most common indication for DBS therapy, with high efficacy in managing motor symptoms. The proven success of DBS in improving motor function as well as reducing medication dependency for Parkinson’s patients is driving the growth.

 

Fastest-Growing Segment: Obsessive-Compulsive Disorder (OCD)

The OCD segment is projected to grow at a CAGR of 12.4% from 2024 -2030, fueled by the FDA’s humanitarian device exemption (HDE) approval for DBS in OCD. DBS is gaining traction as a treatment for OCD, particularly in cases resistant to pharmacological therapies. Increasing awareness and expanded research on the efficacy of DBS for psychiatric conditions.

By End User

Leading Segment: Hospitals

Hospitals held over 50% of the market share in 2023, attributed to integrating DBS devices into neurology departments. Hospitals dominate the market due to their advanced surgical facilities, availability of skilled professionals, and higher patient inflow for complex procedures. Higher investments in hospital infrastructure and advanced neurosurgical equipment are driving the growth.

 

Fastest-Growing Segment: Neurological Clinics

Neurological clinics segment is expected to grow at a CAGR of 10.1% from 2024 - 2030, driven by a rising preference for specialized care. Neurological clinics are becoming increasingly popular due to their specialization in treating neurological conditions and outpatient services. The driving factors are the patient preference for focused neurological care with shorter waiting times.

By Region

Leading Segment: North America

North America accounts for approximately 40% of the global market, with the U.S. contributing the largest share due to the high prevalence of Parkinson’s disease. North America leads the market, driven by advanced healthcare infrastructure, high adoption of DBS technology & significant investments in neurological research. Favorable reimbursement policies and robust R&D activities are the driving factors.

Fastest-Growing Segment: Asia-Pacific

Asia-Pacific is projected to grow at a CAGR of 12.5% from 2024 to 2030, with China and India emerging as key markets. Asia-Pacific is the fastest-growing region due to improved healthcare infrastructure, rising awareness of neurological disorders, and increasing government support. Expanding healthcare access and rising medical tourism in countries like India for DBS implantation are driving this growth.

 

Deep Brain Stimulation Devices Market Key Players: Industry Leaders Driving Innovation and Neurological Solutions"

• Medtronic plc

• Boston Scientific Corporation

• Abbott Laboratories

• Aleva Neurotherapeutics SA

• NeuroPace, Inc.

• Functional Neuromodulation Ltd.

• SceneRay Corporation

• Neuronetics, Inc.

• LivaNova PLC

• FHC, Inc.

 

Deep Brain Stimulation Devices Market Report Coverage

Report Attribute	Details
Forecast Period	2023 – 2030
Market Size Value in 2023	USD 1.5 Billion
Revenue Forecast in 2030	USD 3.2 Billion
Overall Growth Rate	CAGR of 9.8%
Base Year for Estimation	2022
Historical Data	2017 – 2021
Unit	USD Million, CAGR (2023 – 2030)
Segmentation	By Product Type, By Application, By End User, By Region
By Product Type	Single-Channel Devices, Dual-Channel Devices
By Application	Parkinson’s Disease, Essential Tremor, Dystonia, OCD, Epilepsy, Other Neurological Disorders
By End User	Hospitals, Neurological Clinics, Ambulatory Surgical Centers
By Region	North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country Scope	US, Canada, UK, Germany, France, China, Japan, India, etc.
Pricing and Purchase Options	Customized options available

 

Future Outlook

The future outlook for the Deep Brain Stimulation (DBS) Devices Market is highly promising, driven by advancements in technology, expanding therapeutic applications, and the increasing incidence of neurological disorders. Emerging markets in Asia-Pacific, with an anticipated CAGR of 12.5% from 2024-2030, are expected to drive future growth due to increasing healthcare investments & awareness of DBS technology. Innovations such as directional leads & closed-loop systems are enhancing device precision, further bolstering market adoption. The DBS devices market is poised to become an integral component of advanced neurological care, offering improved life quality for millions of patients worldwide.